Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer
- PMID: 9676833
Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer
Abstract
The activation of telomerase and stabilization of telomeres are thought to be required for cellular immortality and oncogenesis. Three major components of human telomerase--human telomerase RNA (hTERC), telomerase-associated protein (TEP1), and human telomerase catalytic subunit (hTERT)-have recently been identified. However, the roles played by these subunits in the regulation of telomerase activity are still unclear. In the present study, a total of 37 urothelial cancers, including one metastatic lesion, and adjacent normal tissues as well as cell lines derived from bladder cancers were examined for the expression of each telomerase subunit. Reverse transcription-PCR analysis revealed that more than 90% of urothelial cancers expressed hTERT mRNA, whereas less than 20% of normal adjacent tissues did. In contrast, hTERC and TEP1 mRNA were commonly expressed in both cancers and normal tissues. All of the three cell lines derived from bladder cancer expressed each of the telomerase subunits, whereas the two normal primary fibroblast cell lines expressed hTERC and TEP1 mRNA but not hTERT mRNA. Telomerase activity was examined using telomeric repeat amplification protocol assay. All of the cancers examined exhibited telomerase activity, whereas only 2 of 12 normal tissues exhibited weak activity. There was a significant association of telomerase activity with hTERT mRNA expression but not with hTERC or TEP1 mRNA expression. These findings provide strong evidence that the expression of hTERT is a rate-limiting determinant of the enzymatic activity of human telomerase and that the up-regulation of hTERT expression may play a critical role in human carcinogenesis.
Similar articles
-
Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.Cancer Res. 1998 Apr 1;58(7):1558-61. Cancer Res. 1998. PMID: 9537264
-
Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.Clin Cancer Res. 1998 Nov;4(11):2807-10. Clin Cancer Res. 1998. PMID: 9829746
-
Expression profile of telomerase subunits in human pleural mesothelioma.J Pathol. 2000 Jan;190(1):80-5. doi: 10.1002/(SICI)1096-9896(200001)190:1<80::AID-PATH498>3.0.CO;2-7. J Pathol. 2000. PMID: 10640996
-
Expression of telomerase genes in thyroid carcinoma.Int J Oncol. 2002 Aug;21(2):265-72. Int J Oncol. 2002. PMID: 12118320 Review.
-
[Telomerase, cell immortality and cancer].Hokkaido Igaku Zasshi. 2001 May;76(3):127-32. Hokkaido Igaku Zasshi. 2001. PMID: 11481865 Review. Japanese.
Cited by
-
Target expression of Staphylococcus enterotoxin A from an oncolytic adenovirus suppresses mouse bladder tumor growth and recruits CD3+ T cell.Tumour Biol. 2013 Oct;34(5):2863-9. doi: 10.1007/s13277-013-0847-3. Epub 2013 May 19. Tumour Biol. 2013. PMID: 23686803
-
Targeted Diphtheria Toxin-Based Therapy: A Review Article.Front Microbiol. 2019 Oct 18;10:2340. doi: 10.3389/fmicb.2019.02340. eCollection 2019. Front Microbiol. 2019. PMID: 31681205 Free PMC article. Review.
-
Telomere and Telomerase Therapeutics in Cancer.Genes (Basel). 2016 May 26;7(6):22. doi: 10.3390/genes7060022. Genes (Basel). 2016. PMID: 27240403 Free PMC article. Review.
-
The hTERT-VNTR2-2nd alleles are involved in genomic stability in gastrointestinal cancer.Genes Genomics. 2019 Dec;41(12):1517-1525. doi: 10.1007/s13258-019-00882-y. Epub 2019 Nov 5. Genes Genomics. 2019. PMID: 31691174
-
hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics.Oncol Lett. 2014 Jan;7(1):239-244. doi: 10.3892/ol.2013.1692. Epub 2013 Nov 19. Oncol Lett. 2014. PMID: 24348856 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials